Health Care: Drugs

Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)

$6.68 -0.32 | -4.57%
07/31/14 - 12:46 PM ET
Company Profile
Price and Volume
Recent Price 7.00
52 Week High 7.49
52 Week Low 3.84
Avg. Daily Vol. (Mil) 0.43
Beta (3 year) 2.82
Share Related Items
Mkt Cap (Mil) 421.52
Shares Out (Mil) 60.22
Float (Mil) 37.05
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.90
Current Ratio 1.90
LT Debt/ Equity 0.26
Total Debt / Equity 0.62
Valuation Ratios
Price Earnings n.a.
Price/Sales 52.94
Price/Book 16.36
Price/Cash Flow -11.40
Per Share Data
Earnings -0.70
Sales 0.13
Book Value 0.43
Cash Flow -0.61
Business Summary
Sunesis Pharmaceuticals, Inc., is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
General Information
395 Oyster Point Boulevard
Suite 400
South San Francisc, CA 94080
www.sunesis.com
Industry : Drugs
Sector: Health Care
Employees: 32
CEO: Daniel N. Swisher,Jr
Short Interest
Current Month (Mil) 6.86
Previous Month (Mil) 6.44
Short Interest Ratio (Days) 14.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -52.30
Return on Investments -115.80
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with SNSS

Latest SNSS Headlines from TheStreet

More Financial News for SNSS

Press Releases for SNSS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter